Advancing the care of women with HER2-positive metastatic breast cancer
Last Updated: Friday, July 17, 2026
In a recap of a JADPRO Live 2022 presentation, this review article highlights recent updates to clinical practice for HER2-positive metastatic breast cancer, as well as best practices for monitoring and managing associated side effects.